About 3,840 results
Open links in new tab
Press releases - UCB
Newsroom - UCB
UCB Announces Bepranemab Phase 2a Study Results Accepted for …
UCB off to a Good Start into 2024 – Progressing on its Growth …
UCB and Biogen Announce Positive Topline Results From Phase 3 …
UCB - sustaining growth, now and into the future
UCB completes sale of established brands and updates 2024 …
UCB Presents Encouraging Data on Bepranemab in Early …
UCB announces U.S. FDA approval of RYSTIGGO[®] …
UCB managed 2022 headwinds and is ready for 2023 launches